13G Filing: D E Shaw and Ophthotech Corp. (OPHT)

Page 4 of 6 – SEC Filing

Item 1.
(a) Name of Issuer
Ophthotech Corporation
(b) Address of Issuer’s Principal Executive Offices

One Penn Plaza, 19th Floor

New York, NY 10119

Item 2.
(a) Name of Person Filing

D. E. Shaw & Co., L.P.

David E. Shaw

(b) Address of Principal Business Office or, if none, Residence

The business address for each reporting person is:

1166 Avenue of the Americas, 9th Floor

New York, NY 10036

(c) Citizenship

D. E. Shaw & Co., L.P. is a limited partnership organized
under the laws of the state of Delaware.

David E. Shaw is a citizen of the United States of America.

(d) Title of Class of Securities
Common Stock, $0.001 par value
(e) CUSIP Number
683745103
Item 3.

If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b)
or (c), check whether the person filing is a:

Not Applicable

Item 4.

Ownership

As of May 11, 2017:

(a) Amount beneficially owned:

D. E. Shaw & Co., L.P.:

1,805,361 shares

This is composed of (i) 955,734 shares in the name of D. E. Shaw
Valence Portfolios, L.L.C., (ii) 340,896 shares in the name of D. E. Shaw Oculus Portfolios, L.L.C., (iii) 200 shares
in the name of D. E. Shaw Heliant Capital, L.L.C., (iv) 33 shares in the name of D. E. Shaw Asymptote Portfolios, L.L.C., and (v)
508,498 shares under the management of D. E. Shaw Investment Management, L.L.C.

David E. Shaw:

1,805,361 shares

This is composed of (i) 955,734 shares in the name
of D. E. Shaw Valence Portfolios, L.L.C., (ii) 340,896 shares in the name of D. E. Shaw Oculus Portfolios, L.L.C., (iii) 200 shares
in the name of D. E. Shaw Heliant Capital, L.L.C., (iv) 33 shares in the name of D. E. Shaw Asymptote Portfolios, L.L.C., and
(v) 508,498 shares under the management of D. E. Shaw Investment Management, L.L.C.

(b) Percent of class:
D. E. Shaw & Co., L.P.: 5.0%
David E. Shaw: 5.0%

Follow Iveric Bio Inc. (NASDAQ:ISEE)